TGFB1 and Graves ophthalmopathy: In Graves’ ophthalmopathy, Wu et al.87found that pirfenidone inhibits TGF‐β1 phosphorylation of p38 and JNK in fibroblasts, suggesting it modulates TGF‐β1 pathways involved in fibroblast differentiation and extracellular matrix homeostasis.